Medtronic is trading at $102.62, up +4.56%, alongside sharply higher U.S. markets; no clear company-specific catalyst was identified.

  • The S&P 500 was up 1.71%, the Nasdaq up 2.41%, and the Dow up 2.11%.
  • Medtronic completed its MiniMed separation on November 4 and reported Symplicity study results on November 3; available sources do not link either announcement to the price change.